We are live on
!
Find out more
JC
JBF Capital Portfolio holdings
AUM
$764M
Turnover
38.35%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$453M
AUM Growth
-$25.1M
(-5.3%)
Cap. Flow
-$3.24M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
86.52%
Holding
85
New
10
Increased
5
Reduced
5
Closed
20
Avg Time Held Equity + Options
1.9
years
Top 10 Avg Time Held Equity + Options
3.1
years
Top 20 Avg Time Held Equity + Options
2.3
years
Avg Time Held Equity only
1.9
years
Top 10 Avg Time Held Equity only
3.1
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.3M |
| 2 |
NVIDIA
NVDA
|
+$1.3M |
| 3 |
Snowflake
SNOW
|
+$1.27M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.24M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JBG SMITH
JBGS
|
+$9.46M |
| 2 |
Spectrum Brands
SPB
|
+$781K |
| 3 |
CHRA
Charah Solutions, Inc Common Stock
CHRA
|
+$550K |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$442K |
| 5 |
Enliven Therapeutics
ELVN
|
+$388K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.41% |
| 2 | Consumer Discretionary | 21.24% |
| 3 | Technology | 14.93% |
| 4 | Energy | 13.16% |
| 5 | Financials | 3.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$816B
| – | – |
-3,000
| Closed | -$473K | – |
|
77
DELISTED
SWK Holdings
SWKH
| – | – |
-10,544
| Closed | -$140K | – |
|
78
Teck Resources
TECK
$31.8B
| – | – |
-3,616
| Closed | -$152K | – |
|
|
PRDS
79
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – |
-43,998
| Closed | -$79.6K | – |
|
|
APGN
80
DELISTED
Apexigen, Inc. Common Stock
APGN
| – | – |
-9,130
| Closed | -$3.92K | – |
|
|
KDNY
81
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-11,500
| Closed | -$442K | – |
|
|
GRNA
82
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| – | – |
-50,000
| Closed | -$14.9K | – |
|
|
ISEE
83
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-5,000
| Closed | -$197K | – |
|
84
DELISTED
Steel Connect, Inc. Common Stock
STCN
| – | – |
-7,026
| Closed | -$58.9K | – |
|
|
CHRA
85
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| – | – |
-94,000
| Closed | -$550K | – |
|
Similar funds
UCMOK
EIM
CAAM
KLI
CT
ANRF
NI
HI
JBF Capital's Q3 2023 Portfolio in Review
As of Q3 2023, JBF Capital held 85 positions worth $453M, down 5.3% from $478M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
JBF Capital's Q3 2023 filing shows 10 new, 5 increased, 5 reduced and 20 closed positions. Its largest new stake was Broadcom: 15,000 shares worth $1.25M. The largest sale was JBG SMITH, an estimated $9.46M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Technology.
- JBF Capital's largest Q3 2023 buy was Broadcom: 15,000 shares worth $1.25M.
- JBF Capital added most to Apple in Q3 2023, an estimated $734K increase.
- JBF Capital's biggest Q3 2023 reduction was Enliven Therapeutics, cutting an estimated $388K.
- JBF Capital fully exited JBG SMITH in Q3 2023, selling an estimated $9.46M.
- JBF Capital's ten largest holdings make up 87% of its $453M portfolio in Q3 2023.
- JBF Capital opened 10 new positions and closed 20 in Q3 2023.
- JBF Capital's portfolio value fell 5.3% quarter-over-quarter to $453M.
Based on JBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.